BACKGROUND:No surveys of stress ulcer prophylaxis prescribing in the USA havebeen conducted since 1995. Since that time, the most comprehensive meta-analysisand largest randomized study to date concerning stress ulcer prophylaxis havebeen published.RESULTS:Three hundred sixty-eight surveys were sent to all members of theSection of Pharmacy and Pharmacology of the Society of Critical Care Medicine.One hundred fifty-three (42%) surveys were returned. Representatives from 86%of institutions stated that medications for stress ulcer prophylaxis are usedin a majority (>90%) of patients admitted to the intensive care unit (ICU).Twenty-two per cent of institutions have recommendations for both ICU andnon-ICU settings. Fifty-eight per cent of institutions stated that there wasone preferred medication for stress ulcer prophylaxis, and in 77% of thesehistamine-2-antagonists were the most popular.CONCLUSIONS:There are wide variations in prescribing practices for stressulcer prophylaxis. Institutions should consult published literature and usepre-existing guidelines as templates for developing their own guidelines.
| Identifer | oai:union.ndltd.org:arizona.edu/oai:arizona.openrepository.com:10150/610127 |
| Date | January 1999 |
| Creators | Erstad, Brian L., Barletta, Jeffrey F., Jacobi, Judith, Killian, Aaron D., Kramer, Katherine M., Martin, Steven J. |
| Contributors | Clinical Specialist – Surgery, Department of Pharmacy Practice, Detroit Receiving Hospital, Michigan, USA, Associate Professor, Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, USA, Professor of Surgery, Chief of the Division of General Surgery, Southern Illinois University, USA |
| Publisher | BioMed Central |
| Source Sets | University of Arizona |
| Language | English |
| Detected Language | English |
| Type | Article |
| Rights | © 2002 Barletta et al., licensee BioMed Central Ltd |
| Relation | http://ccforum.com/content/6/6/526 |
Page generated in 0.0021 seconds